11/29/2016
Preliminary Results Suggest Surgery Plus GammaTile™ Extends Median Time to Surgical Site Recurrence
RICHLAND, ...
11/08/2016
Management Continues to Expect Stronger Second Half of Fiscal 2017
RICHLAND, Wash., Nov. 8, 2016 /PRNewswire/ ...
10/20/2016
RICHLAND, Wash., Oct. 20, 2016 /PRNewswire/ -- IsoRay, Inc. (NYSE MKT: ISR) (the "Company"), a medical technology
09/28/2016
Expanded Information and Resources for Brachytherapy and its Efficacy with Multiple Cancers
RICHLAND, Wash., Sept.
09/27/2016
Final Settlement Requires Court Approval
RICHLAND, Wash., Sept. 27, 2016 /PRNewswire/ -- IsoRay, Inc. ("IsoRay") ...
09/08/2016
Management Presenting at Rodman & Renshaw 18th Annual Global Investment Conference on Tuesday, September 13, ...
08/16/2016
RICHLAND, Wash., Aug. 16, 2016 /PRNewswire/ -- IsoRay, Inc. (NYSE MKT:ISR), a medical technology company and ...
07/06/2016
Topic of Two Presentations at the 2016 Annual Meeting of the American Brachytherapy Society and World Congress of ...
06/21/2016
95% of Targeted Cancers Showed No Regrowth of Tumor at the Operative Site
RICHLAND, Wash., June 21, 2016 ...
06/02/2016
RICHLAND, Wash., June 2, 2016 /PRNewswire/ -- IsoRay, Inc. (NYSE MKT: ISR), a medical technology company and ...
05/16/2016
RICHLAND, Wash., May 16, 2016 /PRNewswire/ -- IsoRay, Inc. (NYSE MKT: ISR), a medical technology company and ...
05/10/2016
RICHLAND, Wash., May 10, 2016 /PRNewswire/ -- IsoRay, Inc. (NYSE MKT: ISR), a medical technology company and ...
[dsm_card title=”Media & Public Relations Contact” button_url_new_window=”1″ _builder_version=”4.8.1″ _module_preset=”default” background_color=”#FFFFFF” custom_margin=”||0px||false|false” hover_enabled=”0″ sticky_enabled=”0″]
If you have questions or need help, please contact:
Chuck Padala
Public and Media Relations
[/dsm_card]